Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart
- 1 January 2003
- Vol. 89 (1), 14-18
- https://doi.org/10.1136/heart.89.1.14
Abstract
Heart failure is a systemic disorder characterised by tissue hypoxia and secondary organ dysfunction which occurs in response to various myocardial insults that include ischaemia, viral infections, and toxins. In addition to maladaptive neurohumoral activation, heart failure is associated with an inflammatory state that appears to have a detrimental effect on cardiac function and prognosis. This has led to the suggestion that anti-inflammatory interventions may have therapeutic potential in the symptomatic and prognostic treatment of patients with heart failure. This review considers the role of inhibition of the cytokine tumour necrosis factor α in the treatment of heart failure.Keywords
This publication has 46 references indexed in Scilit:
- Reversible activation of nuclear factor-κB in human end-stage heart failure after left ventricular mechanical supportCardiovascular Research, 2002
- Effects of Tumor Necrosis Factor-α on Basal and Stimulated Endothelium-Dependent Vasomotion in Human Resistance VesselJournal of Cardiovascular Pharmacology, 2000
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or HypertensionJournal of the American College of Cardiology, 1996
- Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsisCritical Care Medicine, 1995
- Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Journal of Clinical Investigation, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989